[Major depressive disorder, antidepressants and sexual dysfunction.] Neuropsychiatrie : Klinik, Diagnostik, Therapie und Rehabilitation : Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater [Neuropsychiatr] Journal article | | Title | [Major depressive disorder, antidepressants and sexual dysfunction.] | | Author(s) | Kinzl JF | | Institution | Dept. für Psychiatrie und Psychotherapie, Klinik für Psychosomatische Medizin, johann.kinzl@uki.at. | | Source | Neuropsychiatr 2009; 23(2):134-138. | | Abstract | Depression and antidepressant therapy have been associated with sexual dysfunction. Studies report wide discrepancies with regard to frequency, gender, and quality of sexual dysfunction. Although sexual side effects are a common reason for non-compliance with medication, information on impairment of sexuality in psychiatric patients is rare. The impact of antidepressant- induced sexual dysfunction is substantial and negatively affects quality of life, self-esteem, mood, and relationship with partner. Sexual side effects resulting from serotonin specific reuptake inhibitors use may be mediated by a number of central and peripheral mechanisms. Some antidepressants such as Bupropion, mirtazapine, and moclobemide have a sexual tolerability profile significantly better than SSRIs, especially escitalopram, paroxetine, venlafaxine, sertraline, or fluoxetine. There are some possibilities for treatment of antidepressantinduced sexual dysfunctions such as waiting for spontaneous remission, reducing the dosage level, substituting the offending drug with other antidepressants, drug holidays, or administration of a phosphodiesterase- 5-inhibitor. These side-effects are increasingly used therapeutically in the context of the common male sexual dysfunction ejaculatio praecox. For this indication short-acting SSRI;s are available. | | Language | GER | | Pub Type(s) | JOURNAL ARTICLE
| | PubMed ID | 19573505 |
|
|
| |
Advertise on this site.
| | |
|
